Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

305.35
+1.430.47%
Post-market: 305.350.00000.00%17:10 EDT
Volume:518.04K
Turnover:157.69M
Market Cap:13.77B
PE:12.16
High:305.74
Open:303.03
Low:300.46
Close:303.92
Loading ...
Feb 04, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 13, 2019

Major Issues Report

Current report, item 8.01
Oct 30, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 30, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 21, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 11, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 12, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jul 31, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jul 31, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 31, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 28, 2019

Major Issues Report

Current report, items 1.01, 2.03, 5.02, 5.07, and 9.01
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 28, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities